Aakash Desai: Bridging the gap between clinical advancements and real-world application
Aakash Desai, Associate Director and Assistant Professor at UAB O’Neal Comprehensive Cancer Center, shared a post on LinkedIn:
“The landscape of immunotherapy for early-stage non-small cell lung cancer (NSCLC) has evolved significantly, with multiple recent approvals enhancing treatment options. However, navigating these advancements can be challenging for both healthcare professionals and patients.
To address this, I collaborated with the Oncology Learning Network to develop patient case-based educational resources.
Our goal is to bridge the gap between clinical advancements and real-world application, ensuring that these therapies are effectively integrated into patient care.
Explore these resources to stay informed about the latest developments and practical strategies in early-stage NSCLC treatment! UAB Medicine UAB O’Neal Comprehensive Cancer Center.
Click here to read more about his case study.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023